Genetic Technologies Limited (GTG.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | - AUD | 0.0% |
| 2023 | 229.27 Thousand AUD | -40.97% |
| 2022 | 388.39 Thousand AUD | 1491.0% |
| 2021 | 24.41 Thousand AUD | -53.28% |
| 2020 | 52.25 Thousand AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | -100.0% |
| 2014 | 2.5 Million AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | -100.0% |
| 2008 | 187.48 Thousand AUD | -74.93% |
| 2007 | 747.79 Thousand AUD | -37.27% |
| 2006 | 1.19 Million AUD | 70.46% |
| 2005 | 699.35 Thousand AUD | 0.48% |
| 2004 | 696.04 Thousand AUD | -0.11% |
| 2003 | 696.77 Thousand AUD | 0.0% |
| 2002 | - AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q4 | - AUD | 0.0% |
| 2024 Q2 | 84.13 Thousand AUD | 0.0% |
| 2024 FY | - AUD | -100.0% |
| 2023 Q2 | 328.41 Thousand AUD | 0.0% |
| 2023 FY | 229.27 Thousand AUD | -40.97% |
| 2023 Q4 | 229.27 Thousand AUD | 0.0% |
| 2022 Q1 | - AUD | -100.0% |
| 2022 FY | 388.39 Thousand AUD | 1491.0% |
| 2022 Q3 | - AUD | -100.0% |
| 2022 Q4 | 388.39 Thousand AUD | 0.0% |
| 2022 Q2 | 33.51 Thousand AUD | 0.0% |
| 2021 Q2 | 116.43 Thousand AUD | 0.0% |
| 2021 FY | 24.41 Thousand AUD | -53.28% |
| 2021 Q3 | - AUD | -100.0% |
| 2021 Q4 | 24.41 Thousand AUD | 0.0% |
| 2020 FY | 52.25 Thousand AUD | 0.0% |
| 2020 Q2 | 137.3 Thousand AUD | 0.0% |
| 2020 Q4 | 240.87 Thousand AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2015 Q2 | 1.5 Million AUD | 0.0% |
| 2015 FY | - AUD | -100.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 Q4 | 2.5 Million AUD | 0.0% |
| 2014 Q2 | 5.35 Million AUD | 0.0% |
| 2014 FY | 2.5 Million AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q2 | 76.89 Thousand AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2009 Q2 | 280.76 Thousand AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 FY | - AUD | -100.0% |
| 2008 Q2 | 13.36 Thousand AUD | 0.0% |
| 2008 Q4 | 187.48 Thousand AUD | 0.0% |
| 2008 FY | 187.48 Thousand AUD | -74.93% |
| 2007 Q4 | 747.79 Thousand AUD | 0.0% |
| 2007 FY | 747.79 Thousand AUD | -37.27% |
| 2007 Q2 | 260.03 Thousand AUD | 0.0% |
| 2006 Q2 | - AUD | 0.0% |
| 2006 FY | 1.19 Million AUD | 70.46% |
| 2006 Q4 | 1.19 Million AUD | 0.0% |
| 2005 FY | 699.35 Thousand AUD | 0.48% |
| 2005 Q4 | 699.35 Thousand AUD | 0.0% |
| 2005 Q2 | 700.22 Thousand AUD | 0.0% |
| 2004 FY | 696.04 Thousand AUD | -0.11% |
| 2003 FY | 696.77 Thousand AUD | 0.0% |
| 2002 FY | - AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Australian Clinical Labs Limited | 55.06 Million AUD | 100.0% |
| BCAL Diagnostics Limited | 400.22 Thousand AUD | 100.0% |
| Genetic Signatures Limited | - AUD | NaN% |
| Healius Limited | 420.8 Million AUD | 100.0% |
| Imagion Biosystems Limited | 750 Thousand AUD | 100.0% |
| Integral Diagnostics Limited | 219.75 Million AUD | 100.0% |
| INOVIQ Ltd | - AUD | NaN% |
| Microba Life Sciences Limited | - AUD | NaN% |
| Monash IVF Group Limited | 59.56 Million AUD | 100.0% |
| Rhythm Biosciences Limited | - AUD | NaN% |
| Sonic Healthcare Limited | 2.69 Billion AUD | 100.0% |